Characteristics of a human monoclonal autoantibody to the thyrotropin receptor: sequence structure and function
- PMID: 15320966
- DOI: 10.1089/1050725041692918
Characteristics of a human monoclonal autoantibody to the thyrotropin receptor: sequence structure and function
Abstract
The properties of a human monoclonal antibody to the thyrotropin receptor (TSHR) (M22) with the characteristics of patient sera thyroid stimulating autoantibodies is described. Similar concentrations (pmol/L) of M22 Fab and porcine TSH had similar stimulating effects on cyclic adenosine monophosphate (cAMP) production in TSHR-transfected Chinese hamster ovary cells whereas higher doses of intact M22 immunoglobulin G (IgG) were required to cause the same level of stimulation. Patient sera containing TSHR autoantibodies with TSH antagonist (blocking) activity inhibited M22 Fab and IgG stimulation in a similar way to their ability to block TSH stimulation. Thyroid-stimulating monoclonal antibodies (TSmAbs) produced in mice inhibited 125I-TSH binding and 125I-M22 Fab binding to the TSHR but the mouse TSmAbs were less effective inhibitors than M22. These competition studies emphasized the close relationship between the binding sites on the TSHR for TSH, TSHR autoantibodies with TSH agonist activity, and TSHR autoantibodies with TSH antagonist activity. Recombinant M22 Fab could be produced in Escherichia coli and the recombinant and hybridoma produced Fabs were similarly active in terms of inhibition of TSH binding and cAMP stimulation. The crystal structure of M22 Fab was determined to 1.65 A resolution and is that of a standard Fab although the hypervariable region of the heavy chain protrudes further from the framework than the hypervariable region of the light chain. The M22 antigen binding site is rich in aromatic residues and its surface is dominated by acidic patches on one side and basic patches on the other in agreement with an important role for charge-charge interactions in the TSHR-autoantibody interaction.
Similar articles
-
Molecular interactions between the TSH receptor and a Thyroid-stimulating monoclonal autoantibody.Thyroid. 2007 Aug;17(8):699-706. doi: 10.1089/thy.2007.0041. Thyroid. 2007. PMID: 17725428
-
Characteristics of a monoclonal antibody to the thyrotropin receptor that acts as a powerful thyroid-stimulating autoantibody antagonist.Thyroid. 2005 Jul;15(7):672-82. doi: 10.1089/thy.2005.15.672. Thyroid. 2005. PMID: 16053383
-
Similarities and differences in interactions of thyroid stimulating and blocking autoantibodies with the TSH receptor.J Mol Endocrinol. 2012 Aug 30;49(2):137-51. doi: 10.1530/JME-12-0040. Print 2012 Oct. J Mol Endocrinol. 2012. PMID: 22829655
-
TSH receptor antibodies.Thyroid. 2007 Oct;17(10):923-38. doi: 10.1089/thy.2007.0239. Thyroid. 2007. PMID: 17900238 Review.
-
Mechanisms of Action of TSHR Autoantibodies.Horm Metab Res. 2015 Sep;47(10):735-52. doi: 10.1055/s-0035-1559648. Epub 2015 Sep 11. Horm Metab Res. 2015. PMID: 26361260 Review.
Cited by
-
Clinical Association of Thyroid Stimulating Hormone Receptor Antibody Levels with Disease Severity in the Chronic Inactive Stage of Graves' Orbitopathy.Korean J Ophthalmol. 2015 Aug;29(4):213-9. doi: 10.3341/kjo.2015.29.4.213. Epub 2015 Jul 21. Korean J Ophthalmol. 2015. PMID: 26240504 Free PMC article.
-
The influence of hepatitis C infection and interferon-alpha therapy on thyrotropin blocking and stimulating autoantibodies in Graves' ophthalmopathy: a case report.Thyroid Res. 2009 Dec 2;2(1):12. doi: 10.1186/1756-6614-2-12. Thyroid Res. 2009. PMID: 19954547 Free PMC article.
-
Unexpected Crosslinking Effects of a Human Thyroid Stimulating Monoclonal Autoantibody, M22, with IGF1 on Adipogenesis in 3T3L-1 Cells.Int J Mol Sci. 2023 Jan 6;24(2):1110. doi: 10.3390/ijms24021110. Int J Mol Sci. 2023. PMID: 36674625 Free PMC article.
-
Autoantibody mimicry of hormone action at the thyrotropin receptor.Nature. 2022 Sep;609(7928):846-853. doi: 10.1038/s41586-022-05159-1. Epub 2022 Aug 8. Nature. 2022. PMID: 35940205 Free PMC article.
-
Receptor-activating autoantibodies and disease: preeclampsia and beyond.Expert Rev Clin Immunol. 2011 Sep;7(5):659-74. doi: 10.1586/eci.11.56. Expert Rev Clin Immunol. 2011. PMID: 21895478 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources